These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 2564632)
1. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding. Paris H; Galitzky J; Senard JM Mol Pharmacol; 1989 Mar; 35(3):345-54. PubMed ID: 2564632 [TBL] [Abstract][Full Text] [Related]
2. Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase. Turner JT; Ray-Prenger C; Bylund DB Mol Pharmacol; 1985 Nov; 28(5):422-30. PubMed ID: 2865671 [TBL] [Abstract][Full Text] [Related]
3. Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304. Galitzky J; Lafontan M; Paris H; Berlan M J Pharmacol Exp Ther; 1989 May; 249(2):592-600. PubMed ID: 2566682 [TBL] [Abstract][Full Text] [Related]
4. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry. Neubig RR; Gantzos RD; Brasier RS Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672 [TBL] [Abstract][Full Text] [Related]
5. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells. McKernan RM; Howard MJ; Motulsky HJ; Insel PA Mol Pharmacol; 1987 Aug; 32(1):258-65. PubMed ID: 3039340 [TBL] [Abstract][Full Text] [Related]
6. Characterization of alpha-2 adrenergic receptors in the OK cell, an opossum kidney cell line. Murphy TJ; Bylund DB J Pharmacol Exp Ther; 1988 Feb; 244(2):571-8. PubMed ID: 2894455 [TBL] [Abstract][Full Text] [Related]
7. In vitro study of alpha 2-adrenoceptor turnover and metabolism using the adenocarcinoma cell line HT29. Paris H; Taouis M; Galitzky J Mol Pharmacol; 1987 Nov; 32(5):646-54. PubMed ID: 2891026 [TBL] [Abstract][Full Text] [Related]
8. Alpha 2-adrenoceptor in HT29 human colon adenocarcinoma cell-line: study of [3H](-)-adrenaline binding. Sénard JM; Mauriège P; Daviaud D; Paris H Eur J Pharmacol; 1989 Mar; 162(2):225-36. PubMed ID: 2566497 [TBL] [Abstract][Full Text] [Related]
9. Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations. Schloos J; Wellstein A; Palm D Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):48-59. PubMed ID: 2888026 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of adenylate cyclase is mediated by the high affinity conformation of the alpha 2-adrenergic receptor. Thomsen WJ; Jacquez JA; Neubig RR Mol Pharmacol; 1988 Dec; 34(6):814-22. PubMed ID: 2904647 [TBL] [Abstract][Full Text] [Related]
11. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor. Gerhardt MA; Wade SM; Neubig RR Mol Pharmacol; 1990 Aug; 38(2):214-21. PubMed ID: 1974694 [TBL] [Abstract][Full Text] [Related]
12. p-[125I]iodoclonidine, a novel radiolabeled agonist for studying central alpha 2-adrenergic receptors. Baron BM; Siegel BW Mol Pharmacol; 1990 Sep; 38(3):348-56. PubMed ID: 1976227 [TBL] [Abstract][Full Text] [Related]
13. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states. Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763 [TBL] [Abstract][Full Text] [Related]
14. Ability of SK&F 104078 and SK&F 104856 to identify alpha-2 adrenoceptor subtypes in NCB20 cells and guinea pig lung. Gleason MM; Hieble JP J Pharmacol Exp Ther; 1991 Dec; 259(3):1124-32. PubMed ID: 1684814 [TBL] [Abstract][Full Text] [Related]
15. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve. Lenox RH; Ellis J; Van Riper D; Ehrlich YH Mol Pharmacol; 1985 Jan; 27(1):1-9. PubMed ID: 2981397 [TBL] [Abstract][Full Text] [Related]
16. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors. Convents A; De Backer JP; Convents D; Vauquelin G Mol Pharmacol; 1987 Jul; 32(1):65-72. PubMed ID: 2885739 [TBL] [Abstract][Full Text] [Related]
17. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine. Woodcock EA; Johnston CI Mol Pharmacol; 1982 Nov; 22(3):589-94. PubMed ID: 6296653 [TBL] [Abstract][Full Text] [Related]
18. Estradiol reduction of the agonist high affinity form of the alpha 2-adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype. Karkanias GB; Etgen AM Mol Pharmacol; 1994 Mar; 45(3):509-16. PubMed ID: 7908407 [TBL] [Abstract][Full Text] [Related]
19. alpha 2-Adrenoceptors in the HT 29 human colon adenocarcinoma cell line: characterization with [3H]clonidine; effects on cyclic AMP accumulation. Bouscarel B; Cortinovis C; Carpene C; Murat JC; Paris H Eur J Pharmacol; 1985 Jan; 107(2):223-31. PubMed ID: 2984004 [TBL] [Abstract][Full Text] [Related]
20. Alpha 1 and alpha 2 Adrenergic receptors in mouse brain astrocytes from primary cultures. Ebersolt C; Perez M; Bockaert J J Neurosci Res; 1981; 6(5):643-52. PubMed ID: 6119369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]